You will be redirected to https://www.worldscientific.com/apbn to view or purchase the issue PDF.
BioBoard • Rockeby Biomed Cancel Agreement to Supply Test Kits to Turkish Poultry Industry • India Launches Healthcare Drive • Japan's Eisai Company Says 11 Die in Alzheimer's Drug Trial • Innovation Dynamics to Set up Office in Perth • Millipore India Sets up EOU to Manufacture Purification Systems for Global Markets • Life Therapeutics to Spin Out Two Divisions into a New Company • GSK to Build Vaccine Facility in Taiwan • H5N1 Bird Flu has Evolved into Two Strains • Biocon to be Investigated for Drug Violations
Special Feature • Biometrics and E-Authentication Biometrics for Inanimate Objects: The Emergence of Commercially Viable 'Materiametrics'
Industry Watch • Australian Drug Discovery Company, Incitive Ltd, Announces Initial Public Offer • Biosignal Collaborates with Ciba Specialty Chemicals • Brisbane's Tissue Therapy Partners Canada's QSV Biologics • Cellestis Signs Agreements on TB and Cytomegalovirus with FIND • Mesoblast Obtained an Exclusive Worldwide License to Commercialize New Drug-eluting Stent Technology • Narhex Life Sciences Ltd: An Emerging Australian Biotechnology Company • Norwood Immunology Collaborates with Australian Stem Cell Center and Monash University • Premier Bionics' Subsidiary Medic Vision Team up with the University of Melbourne and the CSIRO • PharmaEng signs LOI to Purchase Beijing Lixin PharmaTech • Japan's Bioventures Today -- Noas Medical Co Ltd
Research Findings • Singapore Heart, Stroke and Cancer Center Conducts Research on CT Coronary Angiogram
Rules & Regulations • Singapore's TCM Practitioner Board Sets up New Guidelines on Ethical Conduct
General News • TNT Opens Dedicated National Life Science Distribution Center in Shanghai
Commentaries/Analyses • Commercializing Regenerative Medicine Technologies: Achieving Scale in China
Conference Calendar